Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

While AI-driven approaches tout increased speed and lower costs, commercial interests compromise scientific collaboration.

Designed to support clinicians with same-day assessments, the platform aims to improve outcomes while reducing reliance on ...